Canada markets closed

Bio-Rad Laboratories, Inc. (BUWA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
267.20+0.30 (+0.11%)
At close: 08:20AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 7.60B
Enterprise Value 7.37B
Trailing P/E N/A
Forward P/E 26.53
PEG Ratio (5 yr expected) 1.08
Price/Sales (ttm)3.21
Price/Book (mrq)0.91
Enterprise Value/Revenue 3.04
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.94
52-Week Change 3-23.83%
S&P500 52-Week Change 326.14%
52 Week High 3383.80
52 Week Low 3248.50
50-Day Moving Average 3283.11
200-Day Moving Average 3299.79

Share Statistics

Avg Vol (3 month) 32
Avg Vol (10 day) 31
Shares Outstanding 523.45M
Implied Shares Outstanding 628.71M
Float 819.97M
% Held by Insiders 115.23%
% Held by Institutions 179.98%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024


Profit Margin -12.37%
Operating Margin (ttm)8.48%

Management Effectiveness

Return on Assets (ttm)1.69%
Return on Equity (ttm)-3.43%

Income Statement

Revenue (ttm)2.61B
Revenue Per Share (ttm)90.02
Quarterly Revenue Growth (yoy)-9.80%
Gross Profit (ttm)N/A
EBITDA 502.99M
Net Income Avi to Common (ttm)-322.37M
Diluted EPS (ttm)-9.89
Quarterly Earnings Growth (yoy)456.70%

Balance Sheet

Total Cash (mrq)1.65B
Total Cash Per Share (mrq)57.69
Total Debt (mrq)1.4B
Total Debt/Equity (mrq)15.47%
Current Ratio (mrq)6.57
Book Value Per Share (mrq)317.32

Cash Flow Statement

Operating Cash Flow (ttm)346.57M
Levered Free Cash Flow (ttm)120.82M